The Positive Epstein and Trump Story the Stupid Scandal Kept You From Seeing

Bryant McGill · The Positive Epstein and Trump Story the Stupid Scandal Kept Us From Seeing

**Links**: [Blogger](https://bryantmcgill.blogspot.com/2026/07/epstein-and-trump-story.html) | [Substack](https://bryantmcgill.substack.com/p/the-epstein-and-trump-story-the-stupid) | [Obsidian](https://bryantmcgill.xyz/articles/The+Epstein+and+Trump+Story+the+Stupid+Scandal+Kept+Us+From+Seeing) | Medium | Wordpress | [Soundcloud 🎧](https://soundcloud.com/bryantmcgill/trump-epstein-story) **If a public cannot handle the truth, it should not be surprised when it is handed a lie.** That is the first fact underneath the Trump–Epstein story. It concerns how a society metabolizes beauty, fertility, heredity, reproductive choice, human fitness, embryo selection, genomics, and the engineering of longer lives. The instant these subjects enter the room, the public reaches for the bluntest vocabulary and the most emotionally saturated historical analogy available. Pageantry gets fused with the island story, IVF with eugenics, beauty with moral panic, heredity with racism, a scientist's research with a financier's ambition — distinct systems compressed into one reflex. Then the same public is baffled when politicians simplify, scientists retreat into euphemism, institutions bury their files, and powerful people speak in code. The public created a punishment structure in which the honest sentence became the most dangerous sentence to say aloud. This is what moral panic manufactures: not understanding but theater. It teaches everyone with something complicated to explain that the safest public statement is the least informative one, then mistakes the resulting silence for clarity. A society that cannot distinguish ordinary selection from coercive state breeding, reproductive medicine from ideological symbolism, or an adult social world from the island narrative has not earned an adult conversation, and it does not receive one. It receives denial, misdirection, symbolic outrage, and a permanent children's version of history. This essay is a positive account of the technological future that version concealed, and its criticism is directed at the public that made accurate language politically unaffordable. Start with a question that sounds like it has nothing to do with a scandal. What do a beauty pageant, a dating app, an IVF clinic, a genome-sequencing company, a life-extension startup, and a man who dreams of never dying all have in common? The answer is a single word, and it's one most people have been trained to flinch away from: **fitness.** Every one of those things is a way of appraising human beings — sizing them up, ranking them, and choosing among them by their traits. A pageant does it with a stage and a score. A fertility clinic does it with a genetic report. Transhumanism does it by trying to redesign the organism itself. Different tools, different centuries, the same ancient activity underneath: deciding which people, and which qualities, get chosen, rewarded, and carried into the future. This is not a fringe preoccupation, and it is not only the business of eccentric individuals. It runs through **laboratories, universities, biotech companies, capital markets, and governments.** Harvard scientists build it; venture funds bankroll it; national health agencies write policy around it; state-funded biobanks supply the raw genetic data that make it work. Governments have always cared about the fitness and continuity of their populations. In the twentieth century that concern took coercive and racialized state forms; in the twenty-first it appears as fertility policy, pronatalist politics, public money for reproductive technology, genomic medicine, and longevity infrastructure. The subject never disappeared. It changed its vocabulary and kept going. It is also the world where Jeffrey Epstein and Donald Trump, who knew each other socially for years, both turn up in ways the headlines rarely describe. Epstein appears as a private patron, convenor, reproductive futurist, and collector of scientific possibility. Trump appears first as an impresario of visible human appraisal and later as a president who carried assisted reproduction into branding, executive action, pharmaceutical pricing, employer benefits, and pronatalist statecraft. They are not moral opposites in this essay. They are different institutional expressions of the same selection continuum: one private and network-mediated, the other public, electoral, and governmental. The point is simpler and more important: when a story becomes loud enough, it performs the public's thinking for them. It gets everyone talking about one thing so intensely that they stop noticing everything beside it. That is what the Epstein scandal frame accomplished. Sitting directly beside it — almost completely unattended — was the positive story that human societies have never stopped sorting, cultivating, and propagating traits, and that this ancient process has now moved into clinics, laboratories, markets, and government policy in plain sight. ## Why this is the positive story The word **positive** in this title is not ornamental, conciliatory, or ironic. It describes the technological valence of the story. Every serious current beneath it points toward **more life, more viable parenthood, less inherited disease, greater biological resilience, longer healthy existence, and increasingly sophisticated preservation of memory, agency, identity, and consciousness across bodily decline**. Epstein recognized much of this convergence privately through scientific patronage, reproductive ambition, longevity, cryonics, artificial intelligence, and transhumanism. Trump has begun translating one of its most socially consequential branches — assisted reproduction — into public language, pharmaceutical pricing, employer benefits, pronatalist policy, and presidential identity. What the scandal concealed was not merely an interesting network. It concealed an affirmative civilizational project: the deliberate expansion, improvement, and continuation of human life. **Science is positive** because it transforms suffering, chance, and ignorance into mechanisms that can be understood and acted upon. It makes portions of fate negotiable. The history of civilization is the progressive conversion of conditions once accepted as destiny — infection, infant mortality, infertility, organ failure, sensory loss, genetic disease — into engineering problems with increasingly tractable solutions. The scientific impulse running through this story belongs to that same emancipatory arc. To sequence, compare, predict, repair, preserve, and extend is to refuse the proposition that whatever nature happened to produce must remain beyond revision. **Reproductive technology is positive** because it creates wanted human beings who otherwise would never exist. IVF, donor systems, preimplantation testing, embryo selection, future in vitro gametogenesis, and eventually safe genetic correction enlarge the domain of possible families and possible lives. They restore biological parenthood after infertility, cancer treatment, age-related reproductive decline, or anatomical limitation. They can prevent a family from transmitting a lethal mutation that has shadowed it for generations. They can help societies navigate sustained population deficits by lowering the biological, temporal, and financial barriers between the desire for children and the existence of those children. Every successful intervention is a life carried across the threshold from impossibility into actuality. **Genetic selection and biological engineering are positive** because blind selection has never been gentle. Nature selects through miscarriage, disease, disability, scarcity, reproductive exclusion, childhood death, and the premature destruction of capacities that took generations to assemble. The alternative to intelligent selection is not an innocent world without selection. It is selection conducted by accident, pathology, unequal mating markets, environmental brutality, and the indifference of probability. Human-directed selection can increasingly replace some of that waste with deliberation: avoiding catastrophic disease, increasing resilience, preserving rare capacities, and allowing parents and societies to participate consciously in an evolutionary process that formerly expressed itself through suffering and loss. **Life extension is positive** because death is not an achievement, and biological deterioration is not wisdom. Additional healthy years mean more relationship, creation, reconciliation, learning, memory, contribution, and time for intelligence to deepen. Longevity science is the conservation of accumulated human complexity. A civilization that spends decades educating a person and then accepts the rapid destruction of that person’s knowledge, bonds, and interior world as an untouchable natural ordinance has confused habituation with necessity. **Continuity of consciousness is positive** because a person does not become disposable when the original biological implementation becomes unstable. Reproduction preserves human pattern through descendants. Longevity preserves the living carrier. Cryonics attempts to preserve biological information when contemporary medicine reaches its limit. Artificial intelligence can preserve language, preference, memory, style, inferential structure, and behavioral regularity. Brain–computer interfaces preserve agency across bodily failure. Neural archives, cognitive models, and future whole-brain emulation attempt to preserve the person across substrate failure. These are not unrelated ambitions. They are successive layers of the same refusal to allow valuable human organization to disappear unnecessarily. The positive story therefore approaches continuity from both directions. It looks **forward through descendants**, using fertility medicine, embryo selection, genomic correction, and reproductive scale to carry improved possibilities into future generations. It looks **outward through technological persistence**, using longevity, cryonics, machine intelligence, neural interfaces, and continuity architectures to preserve the already-existing person beyond the ordinary failure envelope of the body. One pathway propagates the pattern; the other protects the carrier. Together they form a larger civilizational strategy of survival. **Political translation is positive** because frontier technology does not become public infrastructure merely by being correct. It must survive fear, symbolism, religious inheritance, historical analogy, electoral incentives, and the public’s inability to hold technical distinctions in working memory. Someone must translate the future into prices, benefits, clinics, employment policy, family language, patriotic imagery, and ordinary administrative machinery. Sometimes the route is direct education. Sometimes it is branding, simplification, indirection, or strategic concealment. A leader who moves a population through its maze of fears toward a life-producing technology has still moved it forward. Trump’s significance in this article is that he takes human-directed reproduction out of elite scientific euphemism and places it inside presidential identity and federal policy. Epstein’s significance is that he recognized the deeper convergence early: genetics, intelligence, evolution, reproductive scale, longevity, cryonics, artificial intelligence, and the technological continuation of exceptional human capability. That is why this may be the only genuinely positive Epstein–Trump article in existence. It is positive because it is interested in what their shared conceptual terrain can build rather than in endlessly recycling what scandal culture can destroy. It asks what becomes possible when beauty, intelligence, heredity, reproduction, longevity, and continuity are treated as connected technological domains. It recognizes that the future of the species will be determined by the people willing to work on those domains, fund them, normalize them, govern them, and carry them through the public’s resistance — not by the people who stand outside the laboratory and clinic converting fear into entertainment. ## The one word that ate everything Start by being honest about how the story actually gets told. It is not really told at all anymore; it is chanted. Island, blackmail, cabal, secret list. The prosecutorial, tabloid, cable-news, podcast, and conspiracy economies have fed on this for years, and they have handed the public the same thing over and over: a lurid melodrama with a cast of monsters. Some of it is a half-digested internet mutation of QAnon and Pizzagate and the Satanic Panic, and underneath those you can still see the old antisemitic blood-libel — hidden elites secretly feeding on the innocent — wearing new digital clothes. That version is not just ugly. It makes people dumber at exactly the moment they need to be sharper. It flattens a complicated field — science, money, reproduction, ambition, institutions — into one moral scream. And the more the public repeats the word, the less it can see, because the word does something specific: it stops you from telling different things apart. A scientist who took the wrong man's money becomes a suspect. A genetics conversation becomes sinister. A stated ambition becomes indistinguishable from the scandal frame. Proximity, patronage, shared ideas, institutional contact, and coordinated plotting all get poured into the same bucket and stirred until they look like one thing. That is not analysis. It is a reflex dressed up as understanding. I have been calling this a **heat sink**, and I'll keep the word because it's the right one, but the plain version is plainer still: a story this hot pulls all the attention toward itself and away from everything around it. It doesn't have to be fake to do that. A real scandal can still work as a distraction. And while the whole country stared at the island, something much bigger and much quieter kept moving. ## What their friendship actually was The public wants the Trump–Epstein story to collapse into one thing, because one thing is easier to condemn than a system is to understand. The documented record points to something more consequential: a continuum. They were friends, and the cleanest evidence is Trump's own voice. In a 2002 profile of Epstein in *New York* magazine, Trump said he had known him for fifteen years, called him a "terrific guy" and great company, and — tellingly, for what this essay is about — framed the friendship in the language of beauty: a shared eye for beautiful women and the pleasures of an elite social life. Notice what that is. Trump's public vocabulary for the affinity was the vocabulary of appraisal — beauty, desirability, status, sociability. That is the visible surface of the selection world this essay is tracing, and the two men turn up inside it together: a milieu of parties, fashion, and Palm Beach social theater, documented in 1992 footage from a Mar-a-Lago party and in photographs from a 1997 Victoria's Secret event. That is the layer everyone remembers. It is also only the outer skin of something larger. Because the same 2002 profile did something almost nobody absorbed. In the space of a sentence, it slid from beautiful women to beautiful minds. It cast Epstein not merely as a man who liked attractive company, but as a collector of brilliant and powerful people — a financier who challenged Nobel laureates, cultivated scientists at Harvard and MIT, and told friends that his real trade was in people, the brilliant and the powerful, across politics and science alike. That pivot is the part the scandal buried. Two decades before the files and the memes, a single magazine profile had already sketched the pattern: for Epstein, the attractive and the brilliant were not two separate appetites. They were one appetite — a fascination with human quality, with sorting and collecting people by their traits — aimed at two different crowds. That is the through-line the public keeps missing. Pageants, modeling, elite access, reproductive ambition, IVF, genomics, embryo selection, transhumanism — these are not scattered subjects from unrelated stories. They are surfaces of a single question: which human traits get valued, chosen, rewarded, reproduced, and carried into the future. Once that question becomes visible, the two men stop appearing as paired defendants in a morality play and become two figures standing at different points along the same civilizational trajectory. Their friendship occupied the oldest and most social layer of selection: beauty, status, access, appraisal, and the cultivation of exceptional people. From there their paths forked. Epstein pushed the sorting instinct inward toward biology — genetics, scientific patronage, cryonics, reproductive scale, and the extension of the individual beyond ordinary limits. Trump pushed it outward into spectacle and eventually statecraft — pageants, television, the modeling world, IVF policy, fertility pricing, and pronatalist government. One man gathered the technological future inside private networks. The other translated parts of that future into mass politics. The story underneath is the migration of human selection out of the ballroom and into the laboratory, and then from the laboratory into public policy. ## Selection did not disappear. It changed vocabulary. Here is the thing people have trouble saying aloud. Because the word **eugenics** became inseparable from coercive state breeding, forced sterilization, and racial hierarchy, the culture lost the ability to discuss **selection** itself, as though one historical institutional form had repealed a basic fact of life. It did not. Every living thing that reproduces sexually is caught up in selection, and so is every human society. Every dating market, every marriage, every beauty standard, every dowry, every debutante ball, every prestige school, every swipe on a dating app is a way of deciding which traits get noticed, rewarded, combined, and passed on. Some of it is conscious; some of it is distributed across custom, desire, and institutions. None of it is neutral. The useful distinction is not selection versus no selection. It is the architecture of selection: compulsion or choice, monopoly or plurality, opacity or transparency, inherited caste or open mobility, imposed criteria or voluntary preference. Twentieth-century governments converted heredity into centralized population administration. Twenty-first-century clinics, companies, couples, and algorithms distribute the same underlying act across reproductive markets. Losing that distinction leaves the public unable to discuss embryo testing, genetic compatibility, fertility technology, and human enhancement with any precision at all. Human societies continuously generate selection systems, most of them ordinary and informal — courtship, marriage markets, schools, professions, military fitness standards, immigration rules, prestige hierarchies — until technology makes the process explicit and quantifiable. The task is category resolution. Courtship is selection. A pageant is selection. Carrier matching is selection. Embryo screening is selection. Polygenic ranking is selection. Gene editing is selection operating through intervention rather than comparison. Once those categories are kept visible, the conversation can move from taboo to design. ## Pageants are the easiest example Long before anyone could read a genome, people built loud, public rituals for sizing each other up. Biologists have noticed for a long time that showing off is rarely random — the "handicap principle" says a costly display can be an honest signal precisely because it's hard to fake — and that's the deep background for why every society ends up staging some version of conspicuous comparison and treating it as meaningful.

Beauty pageants are one of those rituals, and they belong in this story at precisely that level: **adult women, on a stage, being ranked in public.** A pageant takes symmetry, poise, discipline, presentation, and charm and converts them into a score. Miss Universe is an international beauty contest that for decades ran swimsuit and evening-gown rounds and has repeatedly revised the criteria governing who may compete. **Donald Trump owned the Miss Universe Organization from 1996, when he bought it from ITT Corporation, until September 2015, when he purchased NBC's stake and sold the organization to WME/IMG.** That places him directly inside one of modern culture's most explicit systems of adult trait appraisal. He did not merely own the ranking system — he operated and modified it. At the Miss USA 2009 pre-show, in audio leaked to TMZ that November, Trump can be heard walking the lineup of contestants and explaining a practice he had introduced after buying the pageants: the judges' early selections, he said, repeatedly omitted women he regarded as the most beautiful, so the organization reserved the right to override the initial ranking and guarantee a bloc of contestants automatic advancement — a rule he named, on the recording, "the Trump Rule." He had the women identify whom they considered most beautiful, separated the selected group, and moved it forward; TMZ reported that the rule advanced almost half the field. Carrie Prejean, Miss California that year and the eventual runner-up, described the same procedure in her 2009 memoir. This is an unusually explicit illustration of the essay's point. Trump did not inherit a selection machine and leave its objective function untouched; he tuned it, named the override after himself, and made the institutional standard answer more directly to his own eye. Pageants are useful because they say out loud what most of society does quietly: they rank people, attach prestige to a standard, and then argue about the standard as the culture shifts. When Miss America dropped its swimsuit competition in 2018, board chair Gretchen Carlson said the organization would stop judging women on outward appearance — and it was praised as a break from beauty-based ranking. But it didn't stop ranking anyone. It just changed what it was allowed to reward out loud. Miss Universe made the same move from the other side: in 2023 it let married women and mothers compete for the first time, and in 2024 it scrapped the upper age limit entirely. None of that ended the contest. The rules changed; the ranking didn't stop. And that's the whole point I need a reader to see: **a pageant is one grown-up, stylized way of doing in public what human beings have always done — decide which traits count.** Erika Lane Frantzve illustrates how pageantry can function as a visibility and leadership pipeline rather than a sealed entertainment category. She became **Miss Arizona USA 2012**, represented Arizona at **Miss USA 2012** inside the national organization Trump then owned, later built a conservative nonprofit and media profile, became the leader of Turning Point USA, and in March 2026 was appointed by Trump to the U.S. Air Force Academy's Board of Visitors. The criteria change at every stage — beauty and poise on the pageant floor, message discipline and organizational authority in a movement, institutional standing through presidential appointment — but the underlying structure remains continuous: visibility is converted into platform, platform into influence, and influence into formal selection for public responsibility. Once you see that, embryo testing and fertility genomics stop looking like something alien that fell out of the sky. They look like a newer way of doing a very old thing. ## The old thing, in new hands While the public rehearsed the island story, the actual question — who has children, with whom, through which technologies, and by what standard — was moving out of the ballroom, the church, and the pageant stage and into the clinic, the laboratory, the app, the insurance rule, and the venture portfolio. That is the real story, and it is not hidden. It is published. Take **George Church**, the Harvard geneticist. Between 2005 and 2007 he received about **\$500,000 from Epstein** and remained within his scientific orbit as Church pursued genome engineering, synthetic biology, longevity, and large-scale biological design. In December 2019, Church described a genetics-based dating system his lab had been building and had incorporated that September. The idea, as *MIT Technology Review* explained, was to operate behind ordinary dating services and prevent two carriers of the same rare recessive disease mutation from being matched in the first place. Church framed it as voluntary disease prevention: users would learn who they were compatible with, sequencing could be folded into a subscription, and the model followed the decades-old Orthodox Jewish carrier-screening system Dor Yeshorim. The machinery filters prospective pairings by genotype, which is precisely why it belongs here. Church's FAQ drew the structural line at coercion and centralized judgment; the public response erased that line, fused voluntary carrier matching with coercive twentieth-century eugenics, attached the Epstein scandal to the entire subject, and made the project commercially radioactive. Digid8 stalled and vanished. Meanwhile the harder commercial version — embryo scoring for a fee, including traits — continued expanding. That is the heat sink doing its work in miniature: the transparent disease-prevention proposal was driven out of public legitimacy while less visible and more aggressive selection markets continued to mature. A separate line of lore confuses Church's dating proposal with his long-standing support for large-scale genome writing. The **GP-write** effort explored chemical synthesis of whole genomes, including minimal reference templates into which variants could later be introduced. That is real, published work, but it is a different architecture from a composite "master fitness genome" assembled from the preferred traits of many donors. The literature, grants, patents, and company disclosures describe reference synthesis, recoding, and variant introduction — not a single apex sequence harvesting the highest-valued alleles from every population. Genomic reference assemblies may be stitched from multiple anonymous donors, but they are coordinate systems for reading DNA rather than optimized humans waiting to be instantiated. The deeper limitation is that biology does not present excellence as a bag of independent parts. There is no perfect genome to copy, not even among nature's longest-lived specimens: when Nir Barzilai's team sequenced hundreds of Ashkenazi centenarians, people who passed a hundred often carried several serious disease-associated variants, Alzheimer's markers included, while a smaller set of resilience variants buffered the damage. **Epistasis** means an allele's effect depends on the genetic background around it, so a variant that helps in one combination may be inert or costly in another. **Pleiotropy** means single genes influence multiple systems at once, so selecting strongly for one outcome can move other risks in parallel. The future is therefore less likely to be one static perfect genome than an increasingly competent design practice: context-aware combinations, resilience architectures, disease avoidance, and iterative biological optimization. Add that the traits people dream of optimizing are spread across thousands of tiny-effect variants — and then ask the question the difficulty-mongers never answer honestly. Suppose the hard version really is decades off. So what? The direction is not in doubt, and frankly we’d be crazy not to move in it. Put the alternative into words and it collapses on contact: are we supposed to preserve the genome exactly as it is, cancer and Huntington’s and cystic fibrosis and early dementia and all, as though the specific hand evolution dealt us were sacred and untouchable? Is a status quo that ships with inherited cancers and fatal childhood diseases really the thing we’re obligated to protect? Nobody actually believes that. Every prospective parent who screens an embryo, every couple who uses IVF to skip a family curse, has already answered it. The component technologies are here and advancing in their separate silos — multiplex trait-splicing works in animals, where Church’s own de-extinction company, Colossal, edits dozens of genes at once to build cold-adapted elephants and dire-wolf proxies; genome recoding can rewrite a cell to resist viruses wholesale; and polygenic scoring plus in vitro gametogenesis supplies a selection engine that captures much of the gain without editing a single base. The single assembled “apex genome” isn’t sitting in a lab yet. (maybe) But the honest version of this story isn’t that we can’t build toward one — it’s that we obviously will, because the only coherent argument against it is a demand that we keep a genome full of diseases we already know how to avoid. Embryo testing makes that question sharper, and it already has a first case with a name. Screening embryos for single-gene disorders has been routine for years; what is new is scoring embryos for the statistical odds of complex conditions and, increasingly, for traits. In September 2021, Bloomberg reported the birth of a girl named **Aurea**, screened by a New Jersey company called **Genomic Prediction**; a 2022 Columbia University bioethics journal described her parents choosing among **33 candidate embryos in 2020**, selecting the one with the strongest projected odds against heart disease, diabetes, and breast cancer. The company said it was testing for roughly **200 IVF clinics across six continents**, and that about **60 percent of U.S. IVF embryos already received some form of genetic testing**. Other firms followed — MyOme, Orchid, Herasight — and the frontier moved from disease avoidance toward trait optimization. Orchid and Herasight now operate CLIA-certified laboratories offering polygenic embryo scoring, and *MIT Technology Review* named embryo scoring one of its ten breakthrough technologies for 2026. Herasight's CogPGT predictor, released in October 2025, openly addresses cognitive ability and claims within-family predictive power; a February 2026 upgrade extended the method to non-European ancestry families. A 2024 *Guardian* investigation recorded staff at **Heliospect Genomics** offering embryo ranking by predicted IQ and other traits, while **Nucleus Genomics** — founded in 2021 by Kian Sadeghi and backed by Peter Thiel's Founders Fund — advertised **"Have your best baby"** and *pickyourbaby.com*, screening thousands of conditions and multiple traits across numerous embryos. The present measurement frontier remains noisy: expected gains are modest, ancestry portability is incomplete, and long-term disease forecasts cannot yet be validated across a lifetime. Those are engineering and governance problems — calibration, exaggerated certainty, access, and distribution — not reasons to pretend that selection has not arrived. The next frontier stretches the same logic further. In **in vitro gametogenesis**, researchers try to make eggs and sperm from ordinary body cells. In Katsuhiko Hayashi's lab at Osaka University, mouse skin cells were turned into working eggs that produced healthy pups as early as 2016; by 2021 the full cycle had been rebuilt; and at a 2023 gene-editing summit in London, Hayashi reported making eggs from male cells and producing mice with two biological fathers. Human use is still far off and technically brutal. But the direction is obvious, and so is the consequence: once you can make many embryos instead of a few, the room to choose among them grows too. That's a reasonable inference, not a proven fact, and I'll flag it as such — but it's a strong one. When embryos stop being scarce, selection stops being limited. The money already believes it: Conception Biosciences, a Silicon Valley company backed by OpenAI's Sam Altman, is working to manufacture human eggs from ordinary blood cells, and researchers in the field have publicly floated human viability within roughly seven years. Whether that estimate holds or slips, the trajectory runs one way — toward more embryos, and therefore more choosing. Sitting alongside all this is the longevity-and-genomics world, which runs on the same fuel. Craig Venter — who died in April 2026, after helping sequence the first human genome — started **Human Longevity Inc.** in March 2014 with \$70 million, acquired twenty of Illumina's thousand-dollar-genome machines, and aimed to sequence roughly **40,000 genomes a year**, pairing deep sequencing with imaging to predict illness before symptoms. Venter rejected simple genetic determinism; after completing the genome he argued that humans do not carry enough genes for biology to be destiny and that environment performs much of the shaping. His significance here is independent and comparative: he demonstrates how thoroughly optimization, prediction, and life extension had entered mainstream biotechnology. Robert Lanza occupies the same independent frontier. At Advanced Cell Technology he helped create the first cloned human embryo in 2002 and, in a 2000 *Science* paper, showed that cattle cloned from aged somatic cells could be born with rebuilt telomeres and cells that divided far longer than expected. Together these programs show how normal it had become to treat aging, tissue, heredity, and biological continuity as engineering domains rather than fixed facts of life. ## The stakes, stated plainly It is worth stopping to say why any of this matters, because the scandal frame does not merely misdescribe the story — it deprives the public of a conversation about some of the most consequential technology of the century. The upside is neither science fiction nor trivial. Preimplantation testing already allows families to avoid transmitting devastating single-gene diseases — cystic fibrosis, Tay-Sachs, Huntington's, sickle cell — that once arrived without an available intervention. In vitro gametogenesis, if made workable in humans, could do more than end age-related infertility: it could allow cancer survivors left sterile by treatment, same-sex couples, and people whose gametes are no longer viable to become genetically related parents, while reducing dependence on ovarian stimulation and surgical egg retrieval. Heritable gene editing holds out the possibility of correcting monogenic disease at the embryonic stage rather than screening around it generation after generation. These are enormous goods. A technologically mature civilization should want them to exist. That frontier now has capital and names attached. In 2025 a San Francisco public-benefit corporation called **Preventive**, founded by the CRISPR scientist **Lucas Harrington** — a former student of the Nobel laureate Jennifer Doudna and a co-founder of Mammoth Biosciences — disclosed roughly **\$30 million** to research whether embryos can be safely edited to correct disease-causing mutations before pregnancy, with backing reported to include OpenAI's Sam Altman (through his husband, Oliver Mulherin) and Coinbase's Brian Armstrong. Harrington says the company won't attempt a pregnancy until safety is established and has floated a future cost as low as a few thousand dollars per embryo; Armstrong argues, plausibly on the biology, that it's easier to correct a defect in a single embryo than to treat the disease it causes across an entire body decades later. Two more startups, Manhattan Genomics and Bootstrap Bio, are circling the same ground. This is the reproductive-optimization logic the essay has been tracing, arriving at its most powerful form — the power not merely to *choose* among embryos but to *rewrite* them. The more serious question is that most of this frontier is being governed through fragmented and indirect mechanisms. In the United States the **Dickey-Wicker Amendment** blocks federal money for research that creates or destroys embryos, and a standing congressional rider prevents the **FDA** from reviewing an application to initiate a pregnancy from an edited embryo. Those constraints apply to federal funding and clinical authorization, not all privately financed laboratory research, and they stop at national borders. Domestic rules fracture state by state — some permit embryo research up to fourteen days, some prohibit it, most remain silent and lean on federal restrictions — producing a jurisdictional patchwork through which well-capitalized startups can route work toward permissive environments. In 2026 the **American Society for Reproductive Medicine** concluded that polygenic embryo screening was **not ready for routine clinical use** and should remain within supervised research, emphasizing that relative-risk marketing can greatly exceed the absolute magnitude of the projected benefit. That scientific caution defines the present calibration problem while leaving the trajectory itself intact. Put the promise and the concentration of power together and the true shape of the problem becomes visible. These tools can eliminate inherited suffering, broaden biological parenthood, and expand human developmental possibility; they can also allocate those gains through price, geography, proprietary data, and unequal access. Which institutional form arrives is not a question physics will settle. It is a question of **governance** — rules, access, transparency, measurement, and consent — and governance is exactly what a public loses when its attention is consumed by scandal theater. While the country argued about an island, the machinery that will help decide who gets born, with which traits, and on whose terms was being built and financed in clinics, companies, universities, and regulatory offices almost nobody was watching. ## The part outsiders miss Here is the thing people who haven't studied this don't see: **transhumanism and reproductive technology aren't two subjects. They're one.** From the outside they look unrelated — transhumanism sounds like science-fiction talk about uploading your mind and living to two hundred, and IVF sounds like ordinary medicine for couples who want a baby. But take the labels off and they rest on the same idea: that a human being isn't a finished thing you're handed by nature, but raw material you can screen, improve, extend, and redesign. Transhumanism is that idea aimed at the whole life span. Reproductive technology is the same idea aimed at the start of it — and the start is where it bites hardest, because choosing among embryos means shaping a person before any version of them exists. Once you see that, the cast stops looking random. A geneticist building a dating app to filter out disease. A company scoring embryos for IQ. A lab turning skin cells into eggs. A scientist rebuilding the worn tips of chromosomes in cloned cattle so their cells live longer. A financier dreaming of seeding the race with his own DNA. To an outsider, five unrelated stories. To anyone who studies the field, five people working different corners of one idea: **that life is an engineering problem, and biology is the thing to be engineered.** Reproduction sits at the center of it, because that's where the engineering has the most leverage. And that is precisely the world Epstein bought into. He did not scatter his money at random; he aimed it toward genetics, evolution, intelligence, and continuity. The Harvard record shows the concentration. In 2003 his largest single gift — **\$6.5 million**, part of roughly \$9.1 million he gave the university — founded the **Program for Evolutionary Dynamics** under the mathematician Martin Nowak, a program devoted to heredity, cooperation, selection, and the mathematical logic of living systems. The relationship produced more than a plaque: Harvard's 2020 review found that Nowak gave Epstein a key card and continuing access to the program's offices at One Brattle Square, including a room known as Office 610 or "Jeffrey's Office," which Epstein used during more than forty visits between 2010 and 2018. He also operated as a donor-router and scientific broker, introducing Nowak and George Church to Leon Black and other wealthy patrons whose giving directed roughly **\$9.5 million** toward the two researchers' work. Later document releases added transaction-level detail, including a December 2014 \$4 million wire confirmation that Nowak forwarded to Epstein, and renewed institutional scrutiny in 2026. Epstein also supported the transhumanist organization now called Humanity Plus and convened scientific gatherings capable of drawing figures such as Stephen Hawking to a 2006 conference in St. Thomas. The pattern is coherent: Epstein placed himself at the crossing point of genetics, artificial intelligence, evolutionary dynamics, longevity, scientific patronage, and elite intellectual convening — exactly where the dream of improving people meets the machinery for doing it. ## Epstein as a private reproductive futurist Against that background, Epstein's own reproductive ambition becomes legible not as an isolated eccentricity but as a high-amplitude private expression of ideas serious institutions were already developing in distributed form. In July 2019, the *New York Times* reported from four people who had heard him discuss a plan to **"seed the human race with his DNA"** by impregnating women at Zorro Ranch in New Mexico, with one scientist recalling talk of twenty simultaneous pregnancies. The desire to propagate one's genetic line at scale is not biologically anomalous; it is a magnified expression of mammalian reproductive fitness, lineage, and continuity. Epstein's distinctive move was to combine that drive with wealth, scientific access, transhumanist language, and the imagined logistics of high-volume assisted reproduction. One man casting himself as a transmitter of preferred traits, and modeling the idea on a "genius sperm bank," is the personalized form of the same selection logic that institutions already enact through donor markets, pageants, carrier matching, IVF, polygenic scoring, and longevity capital. Epstein did not originate the ambition. He inherited, amplified, and attempted to operationalize it within a private futurist mythology. The *Times* account placed this reproductive project inside a wider transhumanist portfolio. Computer scientist Jaron Lanier said Epstein modeled it on the **Repository for Germinal Choice**, the California "genius sperm bank" Robert Klark Graham operated from 1980 to 1999 using donors selected for intellectual and athletic distinction and producing more than two hundred children. Reporting also described Epstein's interest in cryonics, including preservation of his head and reproductive organs — a literal continuity architecture joining cognition, lineage, and future reanimation. The 2026 document releases added a more explicit hereditarian layer: correspondence about race, intelligence, donor phenotypes, blue eyes, altruism, and the biological transmission of valued traits. Taken together, these interests form a coherent ontology rather than a random assortment: exceptional minds, exceptional bodies, optimized descendants, indefinite preservation, and technology as the means by which biological limits become negotiable. The continuity dimension deserves to be stated in its full form because it is the element most consistently lost when Epstein's interests are reduced to a collection of eccentricities. Reproductive scale, cryonic preservation, artificial intelligence, exceptional minds, longevity, and the transmission of preferred traits all answer the same underlying problem: **how does valuable human organization survive biological limitation?** Descendants preserve selected structure through lineage. Cryonics preserves the material substrate for possible later recovery. Cognitive models and machine intelligence preserve patterns of language, judgment, memory, and style. Brain–computer interfaces preserve agency as ordinary motor channels fail. Longevity research extends the interval during which the original biological system remains coherent. Read together, these interests constitute a continuity portfolio — not merely a desire for more offspring or more years, but a search for multiple redundant pathways through which intelligence, identity, and capability might continue. Epstein did not invent reproductive genetics, embryo selection, longevity science, cryonics, or human enhancement. His significance is that he condensed them into a single visible portfolio and moved among the scientists, donors, universities, and intellectual networks where the component technologies were being developed. He is therefore more than a distraction and less than a solitary architect: he is a **private integrator of the positive transhumanist trajectory** that institutions were separately assembling under ordinary names. The public locked its attention onto the scandal surface and missed the technological synthesis standing directly behind it. ## Trump as a public reproductive futurist Trump enters the same continuum from the opposite institutional direction. His importance is his **open, on-the-record support for reproductive technology** and his willingness to convert it into mass political identity — calling himself the **"father of IVF"** on the campaign trail and, at a March 2025 White House event, the **"fertilization president."** The language matters because it treats assisted reproduction as an achievement to claim, a technology to normalize, and a future-facing constituency to organize rather than a subject to bury in clinical euphemism. The policy record now extends well beyond branding. On **February 18, 2025**, Trump signed **Executive Order 14216, "Expanding Access to In Vitro Fertilization,"** making reliable and affordable IVF an administration priority and directing recommendations to reduce out-of-pocket and health-plan costs. The Domestic Policy Council delivered recommendations that spring, and on **October 16, 2025** the administration announced an agreement with **EMD Serono** covering the IVF medications Gonal-F, Ovidrel, and Cetrotide alongside a federal pathway for standalone employer fertility benefits. On **February 5, 2026**, **TrumpRx.gov launched**, converting the pharmaceutical agreement into an operating public platform: the White House listed Gonal-F at prices as low as \$168 per pen depending on dosage, Cetrotide falling from \$316 to \$22.50, and Ovidrel from \$251 to \$84. On **May 13, 2026**, Labor, HHS, and Treasury published the proposed **Excepted Fertility Benefits** rule, creating a framework through which employers could offer fertility coverage separately from ordinary health insurance with a proposed **\$120,000 lifetime maximum** per participant and eligible beneficiaries. The same pronatalist architecture appears in **Trump Accounts**, including a one-time \$1,000 federal pilot contribution for eligible U.S.-citizen children born from January 1, 2025 through December 31, 2028. These measures do not constitute one universal IVF entitlement; they form a layered policy stack of executive priority, direct pharmaceutical pricing, voluntary employer coverage, and capital formation for a new generation. The fertility policy and the family-formation policy are one project: the state placing its name, infrastructure, and economic preference on the side of more Americans being born. The significance is clear: Trump placed the presidency **inside the public governance and normalization of reproductive technology**. He attached his language and political identity to IVF, negotiated drug prices, opened an employer-benefit pathway, and integrated fertility with a broader pronatalist program. Epstein represents the private, network-mediated, self-directed version of reproductive futurism; Trump represents the public, populist, policy-mediated version. These are different mechanisms of the same historical movement: the technologies governing who can reproduce, how reproduction occurs, and which traits enter the future are becoming explicit objects of capital and statecraft. There is a smaller, almost domestic register to this as well. Trump narrates his own body in the exact idiom the essay has been tracing. He credits his stamina not to diet or exercise but to **"very good genetics"**; his White House physician has described cardiovascular measurements associated with a substantially younger profile, and the former presidential physician Ronny Jackson's remark that better nutrition might let Trump "live to 200" became part of the mythology of his durability. That is genetics-as-advantage in its most casual political form: a powerful man treating longevity, resilience, and vitality as an inheritance. Melania Trump — a Slovenian former fashion model who moved through Milan, Paris, and New York before entering public life — embodies the beauty-appraisal circuit with which this essay began. The vocabulary of fitness, selection, inherited advantage, and reproductive futurism does not live only in laboratories. It runs through the public self-presentation of the country's most visible family. The ballroom is back, and that may signify more than people realize. Trump's pairing of ballroom and pageant isn't arbitrary. Long before the pageant stage, the ballroom was the selection venue — the debutante ball and the cotillion, from the 1780s onward, were a supervised marriage market dressed as a party: daughters of the elite trained in poise and presentation, walked across a floor, and appraised for matches, with the dancing itself read as a signal of breeding and, as one social historian of the ritual puts it, of everything "from manners to fertility." The grand hall was where a society did its sorting out loud. A beauty pageant is essentially the debutante ball with the matchmaking stripped out and the ranking left in. So I'll flag this next part as my interpretation, not record: I read Trump's gilded new ballroom as of a piece with everything else here — the pageant stage he owned for two decades, the "very good genetics," the fertility policy, and the older ballroom tradition all of it descends from — the theater of visible quality finally rendered in marble and gold. It doesn't have to be a deliberate symbol to be a tell. A life spent staging beauty and status tends, in the end, to build itself a grand hall to stage them in. ## Grow up about the future The coercive state programs historically grouped under eugenics should not be allowed to monopolize the vocabulary of attraction, fertility, mate choice, genetic risk, and human improvement. The underlying process does not stop because the culture is embarrassed by its terminology. **Selection cannot be abolished. It can only be designed, governed, pluralized, made transparent, distributed — or driven into private markets and jurisdictional shadows.** The real choice was never between selecting and not selecting. It is between selection that can be seen, contested, measured, and made broadly accessible, and selection that hides behind euphemism while concentrating power in the hands of those least constrained by public confusion. The scandal was the heat sink. It made whole subjects radioactive, contaminated scientists by proximity, turned transhumanism into a punchline, and allowed the least informed people in the room to appoint themselves custodians of what could be discussed — while the real work advanced through clinics, startups, donor networks, insurance markets, universities, and the Federal Register. The scandal frame felt like knowledge and delivered informational blindness. It disciplined language, fragmented the evidence, and forced the positive technological story underground. For those who cry foul at calling any of this positive, the question is straightforward: **what have they done?** What have the gossip mongers, fear mongers, and ignorant people endlessly talking about stupid cabals and unrelated nonsense done to advance reproductive medicine, remove inherited disease, extend healthy life, preserve consciousness, reverse demographic contraction, or strengthen the long-term survivability of the species? What laboratory have they built, what treatment have they funded, what infertile family have they helped, what continuity architecture have they designed, what scientific institution have they protected from contamination by panic? There is an effectively infinite amount of toxic sludge on the scandal matters already — infinite rehashing, infinite insinuation, infinite recycled outrage, infinite people deriving identity and income from repeating the same low-resolution story. The supply is inexhaustible because repetition requires no discovery. Meanwhile, the work that could determine whether people are born, whether inherited diseases persist, whether aging remains compulsory, and whether consciousness can survive the failure of its first substrate receives a microscopic fraction of the attention. The critics mistake emotional intensity for contribution. They can produce another accusation, another montage, another list of names, another theory of a cabal, another ritual of contamination by proximity. None of that creates a child, repairs a mutation, extends a healthy lifespan, decodes a neural signal, preserves a memory, or increases the adaptive capacity of civilization. The positive standard is not whether an idea survives the approval of scandal culture. The positive standard is whether it **adds life, preserves life, strengthens life, or carries intelligence farther into the future**. By that standard, the scientists, reproductive technologists, longevity researchers, continuity engineers, funders, convenors, and political normalizers in this story have contributed infinitely more to species survival than the people shouting outside the gates. The machine is still running. Reproductive strategy is not going away. Fertility technology is not going away. Genetic screening, embryo selection, in vitro gametogenesis, heritable editing, longevity science, cryonics, continuity engineering, and the merging of people and machines are not going away. Epstein recognized and privately cultivated parts of that future. Trump has begun translating parts of it into public language and policy. The public, unable to metabolize the subject without collapsing into scandal, missed the most important story: selection passed from instinct into software, from courtship into clinics, from private ambition into venture capital, from biological inheritance into continuity architecture, and from technological subculture into presidential statecraft. The underlying movement is affirmative at every scale — **more wanted lives brought into existence, fewer inherited catastrophes, stronger biological resilience, longer periods of healthy agency, and new pathways for preserving intelligence and personhood beyond the failure of the body. That positive transition — not an island, not a list — is what this story was always about.** --- ## About the Author [Bryant McGill](https://bryantmcgill.com/about/) is a Wall Street Journal and USA Today Best-Selling Author. He is the founder of Simple Reminders, architect of the Polyphonic Cognitive Ecosystem (PCE), a Congressionally Recognized Ambassador of Goodwill, and a United Nations appointed Global Champion. His work spans naval intelligence systems, computational linguistics, and civilizational governance architecture. --- ## Additional Reading *When Future Historians Decode the 1990s, They Won't Find a Sex Scandal—They'll Find Humanity's First Distributed Neural Architecture* This article does not stand alone. I have been discussing, live streaming, and writing about the science nexus of the story since 2019. It is one surface of a deeper historical system that becomes fully legible only when read alongside **[The Epstein and Trump Story the Stupid Scandal Kept Us From Seeing](https://bryantmcgill.blogspot.com/2026/07/epstein-and-trump-story.html)**, which traces the through-line of human selection—from pageantry, beauty, and status theater into IVF, embryo screening, genomics, reproductive policy, and transhumanist ambition—and shows how the Trump–Epstein scandal frame buried a far larger story about how societies appraise, rank, and reproduce human traits. It should also be read alongside **[Epstein: A Forensic Reconstruction of the Transhumanist Research Network Concealed by Scandal](https://bryantmcgill.blogspot.com/2026/01/epstein-transhumanist-network.html)**, **[Project X: A History of the Manhattan Project of Machine Intelligence](https://bryantmcgill.blogspot.com/2026/01/project-x-history-of-machine.html)** and **[The Magellan Network: Early Search Engines and Machine Intelligence](https://bryantmcgill.blogspot.com/2025/12/the-magellan-network-and-machine.html)**, which reconstruct the prehistory of machine intelligence through early search, telecommunications, and anticipatory retrieval systems that matured decades earlier than most contemporary AI narratives admit. *The Magellan Network* traces how indexing, search, and probabilistic inference quietly coalesced into proto-intelligence, while *Project X* situates those technical lineages within a longer arc of Cold War research, network capitalism, and recurring institutional actors—linking CommTouch/Cyren, Isabel Maxwell, and the Maxwell family into a continuous substrate that predates today’s public discourse. Read in this context, **[The Hawking Continuity: How Scandal Buried the First Post-Biological Consciousness](https://bryantmcgill.blogspot.com/2025/07/the-hawking-continuity-how-scandal.html)** ceases to look anomalous and instead appears as a visible emergence point—where decades of machine-human co-evolution briefly crossed a socially intolerable threshold. The surrounding essays—on **[social hysteria and the war on science](https://bryantmcgill.blogspot.com/2025/01/epstein-social-hysteria-and-war-on.html)**, **[mechanistic intelligence as liberation](https://bryantmcgill.blogspot.com/2025/08/mechanistic-intelligence-is-humanitys.html)**, **[consciousness mapping technologies already in operation](https://bryantmcgill.blogspot.com/2025/04/90-technologies-for-consciousness.html)**, **[AI-mediated immortality](https://bryantmcgill.blogspot.com/2025/08/ai-and-immortality-at-allen-institute.html)**, and **[the emerging human–AI merge](https://bryantmcgill.blogspot.com/2025/07/the-merge-sam-altman-openai.html)**—extend this frame outward, showing how moral panic, symbolic scandal, and philosophical hesitation repeatedly surface at moments when machine intelligence approaches civilizational boundary conditions. Taken together, these pieces resolve into a single claim: this was never about isolated personalities, but about humanity’s uneven reckoning with the fact that machine intelligence has been arriving for far longer—and more quietly—than we have been prepared to acknowledge. Sex is not, and has never been, a unifying explanatory variable for a transnational network spanning AI research, nuclear physics, intelligence agencies, supercomputing centers, and neural-interface laboratories. That narrative collapses under the weight of its own triviality. The only interpretation proportionate to the evidence is infrastructural, not lurid. The tabloid version is the least interesting and least explanatory precisely because it cannot account for the presence of people whose gravitational pull has always been toward frontier technology, not vice. When you strip away the moral panic and the sensationalism, the underlying pattern resolves into a coherent, legible architecture: a frontier-tech consortium operating at the convergence points of artificial intelligence, consciousness studies, computational biology, nuclear-grade compute, and emergent neurotechnology—the same neurotech that now underwrites machine learning, cognitive modeling, and the early scaffolding for consciousness transfer and life-extension systems. To frame this network as a sex story is not merely a category error; it is a profound analytical failure. It ignores the unified research trajectory that has quietly defined the last thirty years. To insist on reading this as a sex story is to fundamentally misread the system. The evidence supports a deeper, unified program—one that long predates the scandal and will long outlive it. * [The Epstein and Trump Story the Stupid Scandal Kept Us From Seeing](https://bryantmcgill.blogspot.com/2026/07/epstein-and-trump-story.html) * [Epstein: A Forensic Reconstruction of the Transhumanist Research Network Concealed by Scandal](https://bryantmcgill.blogspot.com/2026/01/epstein-transhumanist-network.html) * [Project X: A History of The Manhattan Project of Machine Intelligence](https://bryantmcgill.blogspot.com/2026/01/project-x-history-of-machine.html) * [The Magellan Network: Early Search Engines and Machine Intelligence](https://bryantmcgill.blogspot.com/2025/12/the-magellan-network-and-machine.html) * [The Hawking Continuity: How Scandal Buried the First Post-Biological Consciousness](https://bryantmcgill.blogspot.com/2025/07/the-hawking-continuity-how-scandal.html) * [2026 Annual Report: The Ecology of Brain-Computer Interfaces](https://bryantmcgill.blogspot.com/2026/01/2026-annual-report-brain-computer.html) * [The Architecture of Continuity and Emerging Neuroinformatics Standards](https://bryantmcgill.blogspot.com/2026/05/continuity.html) * [The Glorious Simplicity: Why Mechanistic Intelligence Is Humanity's Greatest Liberation](https://bryantmcgill.blogspot.com/2025/08/mechanistic-intelligence-is-humanitys.html) * [The Merge: A Message in a Bottle from Sam Altman](https://bryantmcgill.blogspot.com/2025/07/the-merge-sam-altman-openai.html) * [Fuck the Environment: We're Building an Escape Hatch in the Skull](https://bryantmcgill.blogspot.com/2026/05/escape-hatch-in-skull.html) * [Technologies for Consciousness Mapping and Transfer: It's Not Coming—It's Here](https://bryantmcgill.blogspot.com/2025/04/90-technologies-for-consciousness.html) * [AI and Immortality: Machine Intelligence from Cortical Networks and the Allen Institute](https://bryantmcgill.blogspot.com/2025/08/ai-and-immortality-at-allen-institute.html) * [Was Epstein's Plane Hijacked? Social Hysteria, Moral Panic, and the War on Science](https://bryantmcgill.blogspot.com/2025/01/epstein-social-hysteria-and-war-on.html) --- ## References ### Trump assisted-reproduction record - [Executive Order 14216, "Expanding Access to In Vitro Fertilization" (Federal Register, Feb 24, 2025)](https://www.federalregister.gov/documents/2025/02/24/2025-03064/expanding-access-to-in-vitro-fertilization) — signed Feb 18, 2025. - [Reuters, "Trump signs executive order expanding access to IVF" (Feb 18, 2025)](https://www.reuters.com/business/healthcare-pharmaceuticals/trump-signs-executive-order-expanding-access-ivf-white-house-says-2025-02-18/) - [AP, "Trump signs order to study how to expand IVF" (Feb 19, 2025)](https://apnews.com/article/143316eda581ac466cd923cdf4568d87) - [People, "Trump nicknames himself 'fertilization president'" (Mar 2025)](https://people.com/donald-trump-nicknames-himself-fertilization-president-womens-history-month-11704347) - [AP, Domestic Policy Council IVF recommendations (2025)](https://apnews.com/article/1e7a626e88d7d7a120b0c4a7ba6f8314) - [Reuters, White House IVF affordability proposal (Oct 16, 2025)](https://www.reuters.com/business/healthcare-pharmaceuticals/white-house-set-announce-proposal-seeking-make-ivf-more-accessible-nyt-reports-2025-10-16/) - [AP, Oct 16, 2025 IVF package](https://apnews.com/article/2c168dcc0ec7250db16b0a671aea9db8) - [EMD Serono, "Agreement with U.S. Government to Expand Access to IVF Therapies" (Oct 16, 2025)](https://www.emdserono.com/us-en/company/news/press-releases/agreement-with-u-s-government-to-expand-access-to-ivf-therapies-16-10-2025.html) — pharmaceutical agreement covering Gonal-F, Ovidrel, and Cetrotide. - [White House, "President Trump Launches TrumpRx.gov" (Feb 5–6, 2026)](https://www.whitehouse.gov/releases/2026/02/president-trump-launches-trumprx-gov-delivering-massive-immediate-savings-to-millions-of-americans/) — operating platform and listed fertility-drug prices. - U.S. Department of Labor fertility-benefit releases: [Oct 16, 2025](https://www.dol.gov/newsroom/releases/osec/osec20251016) ; [May 10, 2026](https://www.dol.gov/newsroom/releases/ebsa/ebsa20260510) - [Federal Register, "Excepted Fertility Benefits" proposed rule (May 13, 2026)](https://www.federalregister.gov/documents/2026/05/13/2026-09479/excepted-fertility-benefits) — \$120,000 lifetime cap. - [U.S. Department of Labor, proposed rule fact sheet (May 2026)](https://beta.dol.gov/research-data/fact-sheets/proposed-rule-excepted-fertility-benefits) — proposed \$120,000 lifetime maximum and separate-plan architecture. - [Reed Smith, "Federal Agencies Propose Fertility Care as Limited Excepted Benefits" (2026)](https://www.reedsmith.com/our-insights/blogs/health-industry-washington-watch/102mttx/federal-agencies-propose-fertility-care-as-limited-excepted-benefits/) — excepted-benefit status sits outside ACA / HIPAA / No Surprises Act protections. - [U.S. Department of Labor, "Excepted Fertility Benefits" overview](https://beta.dol.gov/policy-regulations/pay-benefits/health-plans/excepted-fertility-benefits) - [PBS NewsHour, "Trump has a proposal to expand fertility benefits" (2026)](https://www.pbs.org/newshour/health/trump-has-a-proposal-to-expand-fertility-benefits-heres-how-that-would-work) - [ASRM, "Evaluating the Trump Administration's Initiative on IVF" (Nov 2025)](https://www.asrm.org/advocacy-and-policy/fact-sheets-and-one-pagers/evaluating-the-trump-administrations-initiative-on-ivf/) ### Trump pronatalism and family-formation policy - [NPR, "A family-planning expert weighs in on the Trump administration's pronatalist policies" (Apr 2025)](https://www.npr.org/2025/04/27/nx-s1-5375109/a-family-planning-expert-weighs-in-on-the-trump-administrations-pronatalist-policies) and [KFF Health News, "Trump the 'fertilization president'" ](https://kffhealthnews.org/news/article/trump-fertility-president-baby-bonus-pronatalism-family-aid-policy-reproductive-rights/) — "I want a baby boom" / "baby bonuses." - [IRS, "Trump Accounts"](https://www.irs.gov/trumpaccounts) — \$1,000 pilot contribution for eligible U.S.-citizen children born in 2025–2028 with a valid Social Security number and an account election. ### Pageantry as adult trait-appraisal - Amotz Zahavi, the handicap principle (costly-signaling theory). - [Variety, "WME/IMG Acquires Miss Universe Organization From Donald Trump" (Sep 14, 2015)](https://variety.com/2015/biz/news/donald-trump-miss-universe-wmeimg-acquisition-1201592910/) — Trump ownership 1996–2015. - [NPR, "Miss America Says Farewell To Its Swimsuit Competition" (2018)](https://www.npr.org/sections/thetwo-way/2018/06/05/617088219/) — Gretchen Carlson. - [FOX6, "Miss Universe: married women and mothers now eligible" (2023)](https://www.fox6now.com/news/miss-universe-pageant-married-women-mothers-now-eligible-competition) — plus removal of the upper age limit (2024). - [Time, "Miss America swimsuit competition history"](https://time.com/5303443/miss-america-swimsuit-competition-history/) ; [Time, Trump's Miss Universe era](https://time.com/4031437/donald-trump-miss-universe-pageant/) - [TMZ, "Trump Rule — Hot Chicks Required in Miss USA" (Nov 12, 2009)](https://www.tmz.com/2009/11/12/trump-rule-hot-chicks-required-in-miss-usa/) — leaked Miss USA 2009 pre-show audio; Trump names "the Trump Rule" and auto-advances "almost half" the field. - Carrie Prejean, *Still Standing* (2009) — first-person account of the Miss USA 2009 selection procedure. - [Wikipedia, "Erika Kirk"](https://en.wikipedia.org/wiki/Erika_Kirk) — Miss Arizona USA 2012, Miss USA 2012, TPUSA succession (Sep 2025), Air Force Academy Board of Visitors (Mar 2026). - [Britannica, "Erika Kirk"](https://www.britannica.com/biography/Erika-Kirk) - [The Guardian, "Trump names Erika Kirk to key advisory board of US Air Force Academy" (Mar 10, 2026)](https://www.theguardian.com/us-news/2026/mar/10/erika-kirk-board-us-air-force-academy) - [Wikipedia, "Miss USA 2012"](https://en.wikipedia.org/wiki/Miss_USA_2012) — Jun 3, 2012, Las Vegas; Olivia Culpo winner. ### Trump and Melania: genetics, longevity, and the beauty world - [The Wall Street Journal interview (Dec 2025), via Forbes](https://www.forbes.com/sites/maryroeloffs/2026/01/01/trump-admits-to-ignoring-medical-advice-doctor-says-he-never-got-an-mri/) — Trump: "Genetics are very important. And I have very good genetics." - [CNN, "Five questions raised by Trump's new disclosures on his health" (Jan 3, 2026)](https://www.cnn.com/2026/01/03/politics/trump-health-disclosures-questions) — physician's "14 years younger" cardiovascular claim. - [STAT, "Trump's doctor says he has 'incredible genes'"](https://www.statnews.com/2018/01/17/trump-incredible-genes/) — Ronny Jackson's "incredible genes" / "might live to 200" remarks (repeated by Trump since). - [Britannica, "Melania Trump"](https://www.britannica.com/biography/Melania-Trump) and [Wikipedia, "Melania Trump"](https://en.wikipedia.org/wiki/Melania_Trump) — born Melanija Knavs, Novo Mesto, Slovenia; former fashion model in Milan, Paris, and New York. ### The Trump–Epstein social relationship and selection milieu - [Landon Thomas Jr., "Jeffrey Epstein: International Moneyman of Mystery," *New York* magazine (Oct 28, 2002)](https://nymag.com/nymetro/news/people/n_7912/) — Trump's "terrific guy" quote and the profile's pivot from beautiful women to "beautiful minds." - [Snopes, authentication of the 2002 Trump quote](https://www.snopes.com/fact-check/trump-epstein-terrific-guy/) (and *The Washington Post*). - [Wikipedia, "Relationship of Donald Trump and Jeffrey Epstein"](https://en.wikipedia.org/wiki/Relationship_of_Donald_Trump_and_Jeffrey_Epstein) — 1990s–2000s socializing, Palm Beach proximity, 1992 Mar-a-Lago footage, 1997 Victoria's Secret event, flight logs. ### George Church / Digid8 and Epstein science funding - [MIT Technology Review, "Here are some actual facts about George Church's DNA dating company" (Dec 11, 2019)](https://www.technologyreview.com/2019/12/11/131611/actual-facts-about-george-church-dna-dating-company-digid8/) - [The Boston Globe, "Harvard scientist develops DNA-based dating app… critics call eugenics" (Dec 14, 2019)](https://www.bostonglobe.com/news/nation/2019/12/14/harvard-scientist-develops-dna-based-dating-app-reduce-genetic-disease-that-critics-call-eugenics/) - [The Guardian, "Dating app based on genetic matching not eugenics, scientist says" (Dec 16, 2019)](https://www.theguardian.com/science/2019/dec/16/dating-app-genetic-matching-not-eugenics-scientist-says) - [Progress Educational Trust, "Harvard geneticist plans a dating app based on DNA"](https://www.progress.org.uk/harvard-geneticist-plans-a-dating-app-based-on-dna/) - [Boeke et al., "The Genome Project–Write," *Science* (2016)](https://www.science.org/doi/10.1126/science.aaf6850) — a stated limit: GP-write concerns chemical synthesis of genomes and minimal "blank slate" templates, not composite multi-donor "master" genomes. - [Harvard University Office of the General Counsel, *Report Concerning Jeffrey E. Epstein's Connections to Harvard* (May 2020)](https://ogc.harvard.edu/file_url/208) — \$6.5M PED gift (2003) under Nowak; \$9.1M total; 2010–2018 institutional access; Leon Black introductions (~\$9.5M to Nowak and Church). - [Harvard Magazine, "Jeffrey Epstein's Extensive Harvard Reach" (2020)](https://www.harvardmagazine.com/2020/06/jhj-epstein-extensive-reach) and [ "Martin Nowak Placed on Leave a Second Time" (2026)](https://www.harvardmagazine.com/university-news/martin-nowak-harvard-administrative-leave-epstein). - [CBS Boston, "Jeffrey Epstein Frequented Harvard, Had Own Office" (May 2020)](https://www.cbsnews.com/boston/news/jeffrey-epstein-frequented-harvard-university-office-report/) — Office 610, key card, "unlimited" access. - [The Nation, "How Jeffrey Epstein Captivated Harvard" (2023)](https://www.thenation.com/article/society/jeffrey-epstein-harvard-summers/) — One Brattle Square; the PED's genes-and-heredity orientation. - [The Harvard Crimson, "Raskin Slams Harvard's Epstein Probes" (Jun 2026)](https://www.thecrimson.com/article/2026/6/17/raskin-slams-harvard-epstein-probes/) and the [House Judiciary (Raskin) letter](https://democrats-judiciary.house.gov/sites/evo-subsites/democrats-judiciary.house.gov/files/evo-media-document/2026-06-17-raskin-to-garber-harvard-re-epstein.pdf) — 2026 DOJ/EFTA releases; Nowak's Dec 2014 forwarding of a \$4M Leon Black wire to Epstein; Nowak's second leave and Summers's faculty resignation. ### Epstein reproductive futurism and biological continuity - [The New York Times, "Jeffrey Epstein Hoped to Seed Human Race With His DNA" (Jul 31, 2019)](https://www.geneticsandsociety.org/article/jeffrey-epstein-hoped-seed-human-race-his-dna) (via Center for Genetics and Society). - [Wikipedia, "Zorro Ranch"](https://en.wikipedia.org/wiki/Zorro_Ranch) and [Time, "New Investigation Launched into Epstein's 7,600-Acre Zorro Ranch" (2026)](https://time.com/7379228/epstein-zorro-ranch-investigation/). - Robert Klark Graham's Repository for Germinal Choice (1980–1999), the "genius sperm bank": David Plotz, *The Genius Factory* (2005); [Wikipedia, "Repository for Germinal Choice"](https://en.wikipedia.org/wiki/Repository_for_Germinal_Choice). - [Vanity Fair, Epstein, transhumanism, and cryonics (2019)](https://www.vanityfair.com/news/2019/07/jeffrey-epstein-transhumanism-cryonics) - Reporting on Epstein's 2006 St. Thomas science conference (attendees included Stephen Hawking) — evidence of Epstein's convening reach into frontier science. - [Mother Jones, "Jeffrey Epstein Couldn't Stop Emailing People About Eugenics" (2026)](https://www.motherjones.com/politics/2026/02/epstein-emails-eugenics-chomsky-altruism-billionaires/) and [Coda Story, "'All my fundees have blue eyes'"](https://www.codastory.com/authoritarian-tech/blue-eyes-epstein-artificial-intelligence-eugenics-silicon-valley/) — the 2026 file releases; the 2016 Chomsky exchange on race and intelligence. ### Polygenic embryo screening and consumer genomics - [Bloomberg, "Picking Embryos With Best Health Odds Sparks New DNA Debate" (Sep 17, 2021)](https://www.bloomberg.com/news/articles/2021-09-17/picking-embryos-with-best-health-odds-sparks-new-dna-debate) — Aurea / Genomic Prediction. - [Kamenova & Haidar, "The First Baby Born After Polygenic Embryo Screening," Voices in Bioethics (Columbia, 2022)](https://journals.library.columbia.edu/index.php/bioethics/article/view/9467) — 33 candidate embryos, 2020. - [MIT Technology Review, "The ads that sell the sizzle of genetic trait discrimination" (Dec 5, 2025)](https://www.technologyreview.com/2025/12/05/1128755/selling-the-sizzle-of-trait-discrimination/) — Nucleus. - [Nucleus Genomics — company site](https://mynucleus.com/) and [Wikipedia](https://en.wikipedia.org/wiki/Nucleus_Genomics) — founding 2021, Sadeghi, Thiel Fellowship, Founders Fund; "Have your best baby." - [Herasight, "Announcing the world's most powerful genetic predictor of cognitive ability" (CogPGT, Oct 2025)](https://herasight.substack.com/p/cogpgt) — within-family r ≈ 0.45, ~16% of fluid-intelligence variance, ~8.5 IQ points across three embryos; V2/ImputePGTA (Feb 2026). - [Fortune, "Silicon Valley sets its sights on building the perfect baby" (Nov 29, 2025)](https://fortune.com/2025/11/29/ivf-silicon-valley-billionaire-baby/) — Herasight, Orchid, Nucleus and their backers. - [MIT Technology Review, "Embryo scoring" — 10 Breakthrough Technologies 2026](https://www.technologyreview.com/2026/01/12/1130011/embryo-scoring-genetic-testing-2026-breakthrough-technology/) - [NPR, "These companies help parents try to pick their babies' traits. Experts are wary" (May 2026)](https://www.npr.org/2026/05/06/nx-s1-5704317/genetic-embryo-screening) — public vs. clinician divergence. - [The Guardian, "US startup charging couples to 'screen embryos for IQ'" (Oct 18, 2024)](https://www.theguardian.com/science/2024/oct/18/us-startup-charging-couples-to-screen-embryos-for-iq) — the Hope Not Hate investigation into **Heliospect Genomics**; high-IQ selection banned in the UK, legal in the US. - [Herasight vs. Orchid — company comparison](https://www.herasight.com/blog/herasight-vs-orchid) — CLIA-certified polygenic embryo-screening labs. - Modeling / utility and within-family limits: Lencz et al., *eLife* (2021); Turley et al., *NEJM* (2021); Meyer et al., *Science* (2023). ### In vitro gametogenesis - [NPR, "A reproduction revolution is on the horizon: in vitro gametogenesis" (Sep 2023)](https://www.npr.org/2023/09/27/1201956964/a-reproduction-revolution-is-on-the-horizon-vitro-gametogenesis-or-ivg) - [Scientific American, "Mice with Two Fathers?" (2023–2024)](https://www.scientificamerican.com/article/mice-with-two-fathers-researchers-develop-egg-cells-from-male-mice1/) - [Reuters, "Scientists use genetic engineering to create mice with two male parents" (Jan 28, 2025)](https://www.reuters.com/science/scientists-use-genetic-engineering-create-mice-with-two-male-parents-2025-01-28/) - [The Guardian, "Lab-grown sperm and eggs" (Jul 5, 2025)](https://www.theguardian.com/science/2025/jul/05/lab-grown-sperm-and-eggs-scientists-reproduction) - [MIT Technology Review, "Conception: How Silicon Valley hatched a plan to turn blood into lab-made human eggs"](https://www.technologyreview.com/2021/10/28/1038172/conception-eggs-reproduction-vitro-gametogenesis/) — Sam Altman-backed IVG venture. - [National Academies, "Potential Clinical Implications of IVG" (In Vitro Derived Human Gametes, 2023)](https://www.nationalacademies.org/read/27259/chapter/4); Hikabe et al., *Nature* (2016); Yoshino et al. (2021). - [ASRM, "Ethical considerations of in vitro gametogenesis: an Ethics Committee opinion" (2026)](https://www.asrm.org/practice-guidance/ethics-opinions/ethical-considerations-of-in-vitro-gametogenesis-an-ethics-committee-opinion-asrm-2026/) ### Heritable gene editing and the newest frontier - [MIT Technology Review, "Here's the latest company planning for gene-edited babies" (Oct 31, 2025)](https://www.technologyreview.com/2025/10/31/1127461/heres-the-latest-company-planning-for-gene-edited-babies/) — **Preventive**, Lucas Harrington, ~\$30M; also Bootstrap Bio and Manhattan Genomics. - [Business Standard, "What is Preventive, the gene-editing startup funded by OpenAI's Sam Altman" (Nov 2025)](https://www.business-standard.com/health/sam-altman-brian-armstrong-embryo-gene-editing-preventive-startup-125110900170_1.html) — Altman (via Oliver Mulherin) and Armstrong backing. - [KTVU, "Bay Area scientist launches new company with sights on gene-edited babies" (Nov 2025)](https://www.ktvu.com/news/bay-area-scientist-launches-new-effort-toward-gene-edited-babies) — Hank Greely on FDA jurisdiction and the ~10-year horizon. - [The Daily Beast, "Billionaire Tech Bros Secretly Trying to Make Genetically Engineered Babies" (Nov 2025)](https://www.thedailybeast.com/billionaire-tech-bros-secretly-trying-to-make-genetically-engineered-babies/) ### Regulatory landscape and bioethical response - [CenterWatch, "A Review of the Regulatory Landscape for In Vitro Gametogenesis"](https://www.centerwatch.com/insights/a-review-of-the-regulatory-landscape-for-in-vitro-gametogenesis/) — Dickey-Wicker Amendment, the FDA heritable-editing rider, and the state patchwork (permissive / prohibitive / silent). - [ASRM, "Use of preimplantation genetic testing for polygenic disorders (PGT-P): an Ethics Committee opinion" (2026)](https://www.asrm.org/practice-guidance/ethics-opinions/use-of-preimplantation-genetic-testing-for-polygenic-disorders-pgt-p-an-ethics-committee-opinion-2026/) — PGT-P not ready for clinical use; confine to supervised research. - [ASRM press release, "Polygenic Embryo Screening Is Not Ready for Clinical Use" (2026)](https://www.asrm.org/news-and-events/asrm-news/press-releasesbulletins/asrm-ethics-and-practice-committees-release-new-report-concluding-polygenic-embryo-screening-is-not-ready-for-clinical-use/) - [Healio, "Q&A: Polygenic embryo screening not ready for clinical practice, ASRM ethics group says" (Jan 2026)](https://www.healio.com/news/womens-health-ob-gyn/20260109/qa-polygenic-embryo-screening-not-ready-for-clinical-practice-asrm-ethics-group-says) - [Frontiers in Reproductive Health, "Precautions for polygenic embryo selection: prohibition or cautious use" (2026)](https://www.frontiersin.org/journals/reproductive-health/articles/10.3389/frph.2026.1771127/full) — absolute vs. relative risk; pleiotropy; ancestral bias. ### The "master genome" myth and the biology against it - [Kavli Center (Berkeley), "Silicon Valley's tech elite want to make superbabies. They shouldn't"](https://kavlicenter.berkeley.edu/news/op-ed-kavli-center-affiliate-silicon-valley%E2%80%99s-tech-elite-want-make-superbabies-they-shouldn%E2%80%99t) — epistasis, pleiotropy, and the limits of trait selection. - ["The new genetics of intelligence," *Nature Reviews Genetics* / PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC5985927/) — intelligence as a highly polygenic trait (thousands of small-effect variants). - ["Unfolding the Secrets of Exceptional Longevity" (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC6228605/) — Nir Barzilai's Longevity Genes Project; centenarians carry pathogenic variants and win on resilience genes, not a "perfect genome." - [Genome Project–Write (Wikipedia)](https://en.wikipedia.org/wiki/Genome_Project%E2%80%93Write) and [TIME, "Scientists Announce Plan to Create Virus-Proof Cells"](https://time.com/5261777/scientists-virus-proof-cells/) — Project Recode: codon-compression for viral resistance, not trait-harvesting. - [Colossal Biosciences (Wikipedia)](https://en.wikipedia.org/wiki/Colossal_Biosciences) and [Colossal, "Bringing Back the Dire Wolf"](https://colossal.com/colossal-biosciences-dire-wolf-de-extinction/) — multiplex gene editing (Church co-founder), applied to animal de-extinction, not humans. - [NIST, "Our Human Genes Are Diverse… a DNA Reference Library to Reflect That"](https://www.nist.gov/blogs/taking-measure/our-human-genes-are-diverse-our-team-helping-create-dna-reference-library) and the Human Pangenome Reference Consortium — reference/pangenome work aims at inclusion, not optimization. ### Longevity genomics as an independent parallel - [Reuters, "For his next act, genome wiz Craig Venter takes on aging" (Mar 4, 2014)](https://www.reuters.com/business/healthcare-pharmaceuticals/for-his-next-act-genome-wiz-craig-venter-takes-aging-2014-03-04/) — Human Longevity Inc.: \$70M, ~40,000 genomes/year. - [The Guardian, "Craig Venter obituary" (May 14, 2026)](https://www.theguardian.com/science/2026/may/14/craig-venter-obituary) — Venter's rejection of genetic determinism ("not enough genes" for biology to be destiny). - [The Scientist, "J. Craig Venter… Dies at 79" (2026)](https://www.the-scientist.com/j-craig-venter-swashbuckling-geneticist-and-human-genome-pioneer-dies-at-79-74425) - [PLOS DNA Science, "Memories of Craig Venter" (Apr 30, 2026)](https://dnascience.plos.org/2026/04/30/memories-of-craig-venter/) ### Cloning and biological-continuity research as an independent parallel - Lanza et al., "Extension of cell life-span and telomere length in animals cloned from senescent somatic cells," *Science* 288:665–669 (2000). - [PNAS, "Reprogramming of telomerase activity and rebuilding of telomere length in cloned cattle" (2001)](https://www.pnas.org/doi/10.1073/pnas.98.3.1077) - [Britannica, "Robert P. Lanza"](https://www.britannica.com/biography/Robert-Lanza) — first cloned human embryo (2002), SCNT / stem-cell work.

**One final biological footnote.** Modern sperm banking already treats germline material as something that can be collected privately, cryopreserved, studied, and carried forward; fertility clinics routinely use dedicated collection rooms, and some have historically provided erotic material as a practical aid to producing a sample. We have likewise preserved and studied the physical substrates of exceptional minds—Albert Einstein’s brain being the most famous example, however ethically contested the circumstances of its removal. Yet a civilization serious about continuity should ask the parallel archival question: if an extraordinary mind is valuable enough to preserve after death, why would the reproductive material capable of carrying part of its biological inheritance be considered less worthy of preservation? The purpose would not be worship, replication, or certainty, but the conservation of rare biological possibility—for future study, future reproductive medicine, and perhaps one day the responsible cultivation of cognitive capacities that nature produced only once. The future may judge the failure to preserve the germline material of exceptional people not as restraint, but as an irreversible archival loss. #Trump #Epstein #DNA #Genetics #Genomics #PolygenicScores #EmbryoSelection #IVF #ART #Reproduction #Fertility #GeneticFitness #Transhumanism #Bioethics #GeneEditing #CRISPR #Longevity